IN2014MN01377A - - Google Patents

Info

Publication number
IN2014MN01377A
IN2014MN01377A IN1377MUN2014A IN2014MN01377A IN 2014MN01377 A IN2014MN01377 A IN 2014MN01377A IN 1377MUN2014 A IN1377MUN2014 A IN 1377MUN2014A IN 2014MN01377 A IN2014MN01377 A IN 2014MN01377A
Authority
IN
India
Prior art keywords
amorphous precipitated
protein
dry
protein particles
precipitated protein
Prior art date
Application number
Other languages
English (en)
Inventor
Jan Vos
Andrew John Macleod
Barry Douglas Moore
Original Assignee
Univ Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Strathclyde filed Critical Univ Strathclyde
Publication of IN2014MN01377A publication Critical patent/IN2014MN01377A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591Stabilisation, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN1377MUN2014 2011-12-23 2012-12-24 IN2014MN01377A (enrdf_load_html_response)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201122408A GB201122408D0 (en) 2011-12-23 2011-12-23 Method for preparing dry protein formulations
PCT/GB2012/053265 WO2013093524A2 (en) 2011-12-23 2012-12-24 Method for preparing amorphous precipitated protein particles

Publications (1)

Publication Number Publication Date
IN2014MN01377A true IN2014MN01377A (enrdf_load_html_response) 2015-04-17

Family

ID=45695047

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1377MUN2014 IN2014MN01377A (enrdf_load_html_response) 2011-12-23 2012-12-24

Country Status (9)

Country Link
US (1) US20140348852A1 (enrdf_load_html_response)
EP (1) EP2793863B1 (enrdf_load_html_response)
JP (1) JP2015500869A (enrdf_load_html_response)
BR (1) BR112014015357A2 (enrdf_load_html_response)
CA (1) CA2859288A1 (enrdf_load_html_response)
DK (1) DK2793863T3 (enrdf_load_html_response)
GB (1) GB201122408D0 (enrdf_load_html_response)
IN (1) IN2014MN01377A (enrdf_load_html_response)
WO (1) WO2013093524A2 (enrdf_load_html_response)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11174458B2 (en) * 2007-04-23 2021-11-16 Koligo Therapeutics, Inc. Cell separation apparatus and methods of use
GB201313368D0 (en) * 2013-07-26 2013-09-11 Xstalbio Ltd Novel Reconstitution devices
EP3544724A4 (en) 2016-11-22 2020-10-14 Elektrofi, Inc PARTICLES INCLUDING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND THEIR METHODS OF USE
US11077059B2 (en) 2017-07-25 2021-08-03 Elektrofi, Inc. Electrospraying formation of particles including agents
WO2019201899A1 (en) * 2018-04-16 2019-10-24 Merck Patent Gmbh Method for stabilizing protein comprising formulations by using a meglumine salt.
US11103552B2 (en) 2018-05-10 2021-08-31 Regeneron Pharmaceuticals, Inc. High concentration VEGF receptor fusion protein containing formulations
WO2019226969A1 (en) 2018-05-24 2019-11-28 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
WO2020160323A2 (en) 2019-01-31 2020-08-06 Elektrofi, Inc. Particle formation and morphology
US20220119760A1 (en) * 2019-02-05 2022-04-21 Lindy Biosciences, Inc. Isolated cell culture components and methods for isolating the same from liquid cell culture medium
AU2021257476A1 (en) 2020-04-17 2022-11-03 Elektrofi, Inc. Methods of forming particles by continuous droplet formation and dehydration
CN115844752B (zh) * 2022-11-02 2024-06-28 上海铂舍生物科技有限公司 一种5d超分子胶原蛋白及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0300427D0 (en) 2003-01-09 2003-02-05 Univ Strathclyde Pharmaceutical composition
GB0707938D0 (en) 2007-04-25 2007-05-30 Univ Strathclyde Precipitation stabilising compositions

Also Published As

Publication number Publication date
WO2013093524A3 (en) 2013-08-15
EP2793863A2 (en) 2014-10-29
BR112014015357A2 (pt) 2017-07-11
CA2859288A1 (en) 2013-06-27
JP2015500869A (ja) 2015-01-08
DK2793863T3 (en) 2018-11-12
EP2793863B1 (en) 2018-07-25
WO2013093524A2 (en) 2013-06-27
US20140348852A1 (en) 2014-11-27
GB201122408D0 (en) 2012-02-08

Similar Documents

Publication Publication Date Title
IN2014MN01377A (enrdf_load_html_response)
EP2773746A4 (en) COMPOSITIONS OF ADULT MESENCHYMAL STEM CELLS (MSC) AND PREPARATION METHODS THEREOF
MY167953A (en) Flavoured rods for use in aerosol-generating articles
MY166059A (en) Fusion Proteins for Treating Metabolic Disorders
GB201213868D0 (en) Improvements in or relating to methods of manufacture
ZA201403109B (en) Modulating beta-damascenone in plants
PT2665818T (pt) Expressão de proteínas em plantas
EP2529006A4 (en) METHODS AND COMPOSITIONS FOR IMPROVING PROTEIN PRODUCTION
PL2768935T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
AU340459S (en) Teat for baby bottle
HUE047737T2 (hu) Nyújtott hatóanyag-felszabadítású készítmények fehérjék szembe történõ bejuttatásához, és eljárás ezek elõállítására
EP2697640A4 (en) PROCESS FOR PROFILING THE PHYTOHORMONE MIRROR IN PLANT TISSUE
ZA201300275B (en) Methods for producing proteins in plants
ZA201403059B (en) Increasing virus-like particle yield in plants
IL230519B (en) Virus-based vector constructs used to transform eukaryotic cells
EP2744480A4 (en) GELIFYING COMPOSITIONS WITH LOW PROTEIN CONCENTRATION
GB201115472D0 (en) Improvements in or relating to wheels
ZA201404560B (en) Process for preparing sodium bicarbonate particles
IN2015DN04074A (enrdf_load_html_response)
PL2714327T3 (pl) Ulepszenia sposobów ostrzenia noży
HUE038004T2 (hu) Módok és eljárások apomixis indukálására növényekben
MX351994B (es) Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico.
PH12014500432A1 (en) Stable compositions and methods for preparing the same
IN2012CH02984A (enrdf_load_html_response)
GB201100425D0 (en) Process & dressing